BonomarlotБономарлот
A bone-marrow-derived peptide mixture described in an institute report on anemia. The report concerns the named tissue extract. Stemokin is a separately studied synthetic tripeptide.
What the studies found
Comparison in people · 2011
Bonomarlot: institute clinical report
Institute report of 26 women with nutritional iron-deficiency anemia, divided 15/11. Both groups received conventional care. Reported hemoglobin was higher with adjunctive Bonomarlot; this does not establish stem-cell regeneration or benefit in other conditions.
Study notes · methods, sources and limitations
Participants or model 26 women with nutritional iron-deficiency anemia
Important limitations
- Small adjunctive comparison; allocation and blinding unclear. Reported percentages and table footnotes require reconciliation with the Russian original. Commercial reproduction is not independent replication or peer review.
Institute clinical-report compilation; commercial English reproduction · Originating-institute report; commercial reproduction
About Bonomarlot
Research background
Animal bone-marrow peptide mixture described in an institute anemia report. It is distinct from synthetic Stemokin and from historical Haemalin.
- Compound class
- Archival preparation lead
- Research collection
- Peptide bioregulation · editorial grouping
- Institutions in linked studies
- See individual study records
- Source review
- Review dates and the material assessed are listed with each publication below.
Understanding the evidence
Human research
Small adjunctive anemia comparison
Study methods
Original preparation and study methods await verification
Independent replication
Related reports are not automatically independent evidence
Source access
English institute-report reproduction; Russian original requires comparison
Safety evidence
Clinical safety, product equivalence and interactions not established by this collection
Open a topic for the evidence assessment.
Findings by study
Comparison in people · 2011
Bonomarlot: institute clinical report
Institute report of 26 women with nutritional iron-deficiency anemia, divided 15/11. Both groups received conventional care. Reported hemoglobin was higher with adjunctive Bonomarlot; this does not establish stem-cell regeneration or benefit in other conditions.
Study notes and original source
Bonomarlot: institute clinical report
Animal bone-marrow peptide mixture · Originating-institute report; commercial reproduction
A. A. Veretenko, O. U. Raigorodsky · Institute clinical-report compilation; commercial English reproduction
Institute report of 26 women with nutritional iron-deficiency anemia, divided 15/11. Both groups received conventional care. Reported hemoglobin was higher with adjunctive Bonomarlot; this does not establish stem-cell regeneration or benefit in other conditions.
- Population / setting
- 26 women with nutritional iron-deficiency anemia
- Source reviewed
- English reproduction, pages 4-7, checked. Russian original and complete methods remain review targets.
Study limitations
- Small adjunctive comparison; allocation and blinding unclear.
- Reported percentages and table footnotes require reconciliation with the Russian original.
- Commercial reproduction is not independent replication or peer review.
Reviewed 2026-10-02.
Related compound research
Follow shared publications or research classes. These links do not establish equivalent effects between compounds.
Research collection curated by @PepMariner · editorial standards. Send a source correction ↗
Browse bibliography & PDFs ↗